Toxicology and Forensic Medicine

Open journal

ISSN 2474-8978

Electronic Cigarettes: Toxicity and Addiction

Bashir M. Rezk*, Merhan E. Y. Khedr, Suresh C. Sikka, Wayne J. G. Hellstrom and Asim B. Abdel-Mageed

Bashir M. Rezk, PhD

Associate Professor Department of Natural Sciences Southern University at New Orleans 6400 Press Drive New Orleans, LA 70126, USA Tel. +1(504)284-5405; +1(504)957-8806 E-mail: batteia@suno.edu

Cigarette smoking remains a leading cause of preventable disease and premature death in the United States and other countries. More than 20 million Americans have died as a result of smoking since the 1st Surgeon General’s report on smoking and health was released in 1964.1 Approximately, 2.5 million were non-smokers who died from heart disease or lung cancer caused by exposure to secondhand smoke (SHS).1 Generally, smoking causes 20% of deaths in the United States each year.1 Premature death from complications of smoking is approximately 50%.1 Electronic cigarettes [also known as e-cigarettes and electronic nicotine delivery systems (ENDS)] are battery-operated devices designed to deliver flavored nicotine to users in a vapor, as a substitute to conventional cigarettes, cigars, and pipes. E-cigarettes were invented and patented by the Chinese engineer Hon Lik in 2003. E-cigarettes are now the most commonly used tobacco products among youth and the rising popularity of e-cigarettes among teens. The Centers for Disease Control and Prevention (CDC) reported that more than 3 million middle and high school students were users of e-cigarettes in 2015, compared to 2.46 million in 2014.2,3 In 2013-2014, 81% of youth e-cigarette users cited the availability of appealing flavors as the primary reason for use.4 Candy-flavored, fruit-flavored and menthol-flavored e-cigarettes appeal to adolescents more than tobacco-flavored or alcohol-flavored e-cigarettes, as well as common beliefs that e-cigarettes offer reduced harm.5 The online availability of e-cigarettes allows this age group to easily order them. In May 2016, the National Institute of Drug Abuse (NIDA) reported that, the Food and Drug Administration (FDA) has finalized new regulations to prohibit minors from buying e-cigarettes in person or online.6 The FDA rule extended the regulatory authority to cover all tobacco products, including vaporizers, vape pens, hookah pens, electronic cigarettes, e-pipes, and all other ENDS. FDA now regulates the manufacturing, import, packaging, labeling, advertising, promotion, sale, and distribution of ENDS.

E-cigarettes usually contain major ingredients such as propylene glycol, glycerol, ethylene glycol and polyethylene glycol mixed with concentrated flavors, and optionally, a variable percentage of nicotine.7-9 Other organic compounds can be found in liquid formulated products and/or the vapor phase produced by an e-cigarette unit. These include tobacco specific nitrosoamines such as N-nitrosonicotine, N-nitrosoanabasine, N-nitrosoanabatine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, or tobacco-specific impurities such as cotinine, anabasine, and myosmine.7-9 Data on the daily exposure from liquid-phase aerosol particulate matter in e-cigarettes showed significant formation of formaldehyde and formaldehyde hemiacetals when high voltage (5 V) was applied.10 Geiss et al11 reported that, when considering concentrations in each inhaled puff, the short-term indoor air guideline value for formaldehyde was already exceeded at the lowest wattage of 5 W, which is the wattage applied in most second-generation e-cigarettes. The e-cigarette aerosol also contained metals such as silver, iron, nickel, aluminum, silicate, chromium, lead, tin, and cadmium.12 The concentrations of these elements in e-cigarettes aerosol were higher than or equal to the corresponding concentrations in conventional cigarette smoke.12 Evaluating the potential harm associated with e-cigarette use requires detailed analysis of various aspects of these products and their metabolites, including their toxicological profiles.13

Sellers of e-cigarettes have made a variety of claims indicating that e-cigarettes are safer than conventional cigarettes and that their use facilitates smoking cessation.14 However, e-cigarette manufacturers do not provide complete information on the chemicals used in the manufacturing process, or the chemicals that may be released or synthesized during the aerosol generation process that occurs during use.14 Generally, e-cigarettes required stronger vacuums to smoke than conventional brands, and the effects of this on human health could be adverse.15,16 Health risks associated with the intended use of electronic cigarettes cannot be excluded at present.14

Nearly 50 mg of nicotine are lethal for adults.17 However, for children; a dose of only 6 mg is life-threatening.17 Liquids used in e-cigarettes usually contain up to 36 mg/ml of nicotine. Study of Morean et al18 reported that e-cigarettes smokers, males, and those who purchased their own e-cigarettes reported using the highest nicotine levels. Smoking is a highly efficient form of drug administration.19 Inhaled nicotine enters the circulation rapidly through the lungs and moves into the brain within seconds and reinforces the effects of the drug.19 However, nicotine addiction is more threatening than its toxic effects. This addiction consists of a physical and a psychological component, making cessation particularly hard.19,20 It is possible that e-cigarettes smokers who were more experienced in using the products pulled harder at the devices leading to increased nicotine delivery.16 Since users of electronic cigarettes absorb nicotine when vaping, it is possible that smokers who have switched to e-cigarettes or are using them in addition to conventional cigarettes may maintain nicotine dependence because of the smoking ritual being maintained.16 It is particularly important to protect young people and children from toxicity and addition of e-cigarettes.

CONFLICTS OF INTEREST

The authors declare that they have no conflicts of interest.

1. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA, USA: Centers for Disease Control and Prevention (US); 2014. Web site. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/. Accessed October 2, 2016.

2. Centers for Disease Control and Prevention, CDC. Tobacco use among middle and high school students-United States, 2011-2015. MMWR Morb Mortal Wkly Rep. 2016; 65(14): 361-367. Web site. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6414a3.htm. Accessed October 2, 2016.

3. Centers for Disease Control and Prevention. Tobacco use among middle and high school students-United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2015; 64: 381-385. Web site. http://europepmc.org/abstract/med/25879896. Accessed October 2, 2016.

4. Villanti AC, Johnson AL, Ambrose BK, et al. Use of flavored tobacco products among U.S. youth and adults; findings from the first wave of the PATH Study (2013-2014). 2011. Web site. http://www.cdc.gov/tobacco/data_statistics/tables/trends/infographics/index.htm#youth-tobacco. Accessed October 2, 2016.

5. Pepper JK, Ribisl KM, Brewer NT. Adolescents interest in trying flavoured e-cigarettes. Tob Control. 2016; 1-5. doi: 10.1136/tobaccocontrol-2016-053174

6. National Institute of Drug Abuse. Drug Facts: Electronic Cigarettes (e-Cigarettes). 2016. Web site. https://www.drugabuse.gov/publications/drugfacts/electronic-cigarettes-e-cigarettes. Accessed September 2, 2016.

7. Lindsay JC. Technical Review and Analysis of FDA Report: Evaluation of E-cigarettes. Houston, TX, USA: Exponent Health Sciences; 2009.

8. Trehy ML, Ye W, Handwiger ME, et al. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chrom Rel Technol. 2011; 34: 1442-1458. doi: 10.1080/10826076.2011.572213

9. Thomas B. Njoy Study to Determine Presence of TSNAs in Njoy Vapor. Houston, TX, USA: Ben Thomas Group, LLC; 2009.

10. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015; 372(4): 392-394. doi: 10.1056/NEJMc1413069

11. Geiss O, Bianchi I, Barrero-Moreno J. Correlation of volatile carbonyl yields emitted by e-cigarettes with the temperature of the heating coil and the perceived sensorial quality of the generated vapours. Int J Hyg Environ Health. 2016; 219(3): 268-277. doi: 10.1016/j.ijheh.2016.01.004

12. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013; 8(3): e57987. doi: 10.1371/journal.pone.0057987

13. Orr MS. Electronic cigarettes in the USA: A summary of available toxicology data and suggestions for the future. Tob Control. 2014; 23(Suppl 2): ii18-ii22. doi: 10.1136/tobaccocontrol-2013-051474

14. Henningfield JE, Zaatari GS. Electronic nicotine delivery systems: Emerging science foundation for policy. Tob Control. 2010; 19: 89-90. doi: 10.1136/tc.2009.035279

15. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res. 2010; 12(9): 905-912. doi: 10.1093/ntr/ntq114

16. Series R. Tobacco prevention and tobacco control. Electronic Cigarettes-An Overview. Heidelberg, Germany: German Cancer Research Center; 2013: 19.

17. Cameron JM, Howell DN, White JR, Andrenyak DM, Layton ME, Roll JM. Variable and potentially fatal amounts of nicotine in e-cigarette nicotine solutions. Tob Control. 2014; 23(1): 77-78. doi: 10.1136/tobaccocontrol-2012-050604

18. Morean ME, Kong G, Cavallo DA, Camenga DR, Krishnan-Sarin S. Nicotine concentration of e-cigarettes used by adolescents. Drug Alcohol Depend. 2016; 167: 224-227. doi: 10.1016/j.drugalcdep.2016.06.031

19. Benowitz NL. Nicotine addiction. N Engl J Med. 2010; 362(24): 2295-2303. doi: 10.1056/NEJMra0809890

20. Cobb CO, Hendricks PS, Eissenberg T. Electronic cigarettes and nicotine dependence: Evolving products, evolving problems. BMC Med. 2015; 13: 119. doi: 10.1186/s12916-015-0355-y

LATEST ARTICLES

Unraveling the Mysteries of Type-A Aortic Dissection Using POCUS/Echocardiography

Syeda Rukh*, Sathyanarayana Machani and Milind Awale

doi.

Blood Sample from the Patient

Hypertriglyceridemia-Induced Pancreatitis: A Case Report and Literature Review

Maarten Bulterys, Melvin Willems* and Agnes Meersman

doi.

From Neck Pain to a Life-Threatening Condition: A Case Report

Floris Vandewoude* and Sören Verstraete

doi.

LATEST ARTICLES